MX2020003134A - Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas. - Google Patents

Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas.

Info

Publication number
MX2020003134A
MX2020003134A MX2020003134A MX2020003134A MX2020003134A MX 2020003134 A MX2020003134 A MX 2020003134A MX 2020003134 A MX2020003134 A MX 2020003134A MX 2020003134 A MX2020003134 A MX 2020003134A MX 2020003134 A MX2020003134 A MX 2020003134A
Authority
MX
Mexico
Prior art keywords
acid compound
silicic acid
preparation
pelargonium sidoides
solid
Prior art date
Application number
MX2020003134A
Other languages
English (en)
Inventor
Youn Woong Choi
Byung Gu Min
Sang Min Cho
Do Hyoung Ki
Ji Hyun Ahn
Byung Hoon Lee
Hyung Joon Jun
Won Tae Jung
Kyu Yeol Nam
Dong Gyu Lee
Jin Seong Chung
Original Assignee
Korea United Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53025925&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2020003134(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Korea United Pharm Inc filed Critical Korea United Pharm Inc
Publication of MX2020003134A publication Critical patent/MX2020003134A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con una preparación sólida que incluye un extracto de Pelargonium sidoides y un compuesto de ácido silícico, que se puede formular en una forma sólida mediante adsorción directa del extracto de Pelargonium sidoides sobre un compuesto de ácido silícico, y un método de preparación de la misma. Debido a que la preparación sólida que incluye el extracto de Pelargonium sidoides y el compuesto de ácido silícico de la presente invención tiene mayor estabilidad que una preparación líquida como un jarabe, y no tiene aditivos tales como azúcares, no existe preocupación acerca de una contaminación microbiana o descomposición de la preparación. Además, es posible envasar la preparación sólida individualmente. Debido a que la preparación sólida es menor en volumen que la preparación líquida, es bastante manejable, y también existe una conveniencia de que no son necesarias herramientas adicionales para injerir el fármaco. Además, el ingrediente activo se puede injerir en la cantidad igual cada vez.
MX2020003134A 2013-12-20 2015-12-09 Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas. MX2020003134A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20130159980A KR101497508B1 (ko) 2013-12-20 2013-12-20 펠라고니움 시도이데스 추출물 및 규산 화합물을 포함하는 고형 제제 및 이의 제조 방법

Publications (1)

Publication Number Publication Date
MX2020003134A true MX2020003134A (es) 2020-07-28

Family

ID=53025925

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015016942A MX2015016942A (es) 2013-12-20 2014-12-19 Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas.
MX2020003134A MX2020003134A (es) 2013-12-20 2015-12-09 Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015016942A MX2015016942A (es) 2013-12-20 2014-12-19 Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas.

Country Status (10)

Country Link
US (1) US20160287651A1 (es)
EP (1) EP3082774A4 (es)
KR (1) KR101497508B1 (es)
CN (1) CN105246465B (es)
BR (1) BR112015030090B1 (es)
HK (1) HK1215669A1 (es)
MX (2) MX2015016942A (es)
PH (1) PH12015502499A1 (es)
RU (1) RU2612085C1 (es)
WO (1) WO2015093899A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800002457A1 (it) * 2018-02-07 2019-08-07 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie
KR20200004178A (ko) 2018-07-03 2020-01-13 한국유나이티드제약 주식회사 펠라고니움 시도이데스 추출물을 포함하는 약학 조성물 및 이의 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
KR100210106B1 (ko) * 1997-06-02 1999-07-15 윤종용 냉장고의 급수호스 고정장치
DE102004032439A1 (de) * 2004-07-05 2006-02-02 Iso Arzneimittel Gmbh & Co Kg Verwendung von Extrakten aus Wurzeln von Pelargonium sidoides und Pelargonium reniforme
EP1990062A1 (en) * 2006-02-20 2008-11-12 ASAHI BREWERIES, Ltd. Granules, tablets and method of producing the same
DE102006032326A1 (de) * 2006-07-12 2008-01-17 Dr. Willmar Schwabe Gmbh & Co. Kg Verwendung von Extrakten aus Pelargonium sidoides und/oder Pelargonium reniforme sowie diese Extrakte enthaltende Mittel und pharmazeutische Formulierungen
AU2008238323B2 (en) * 2007-04-17 2013-01-31 Dr. Willmar Schwabe Gmbh & Co. Kg Dry extracts of Pelargonium sidoides and Pelargonium reniforme
KR20100033378A (ko) * 2007-06-22 2010-03-29 브리스톨-마이어스 스큅 컴퍼니 아타자나비르를 함유하는 정제 조성물
CN103041768A (zh) * 2013-01-09 2013-04-17 内蒙古科技大学 一种改性硅酸钙吸附剂的制备方法

Also Published As

Publication number Publication date
EP3082774A1 (en) 2016-10-26
WO2015093899A1 (en) 2015-06-25
RU2612085C1 (ru) 2017-03-02
EP3082774A4 (en) 2017-05-10
BR112015030090A2 (pt) 2017-07-25
BR112015030090B1 (pt) 2023-02-14
CN105246465A (zh) 2016-01-13
HK1215669A1 (zh) 2016-09-09
US20160287651A1 (en) 2016-10-06
PH12015502499B1 (en) 2016-02-22
MX2015016942A (es) 2016-04-25
KR101497508B1 (ko) 2015-03-03
PH12015502499A1 (en) 2016-02-22
CN105246465B (zh) 2018-01-30

Similar Documents

Publication Publication Date Title
AU2017279565B2 (en) RNA formulation for immunotherapy
PH12014502778B1 (en) Antibody formulation
MX338515B (es) Derivados de tetrahidroquinolina utiles como inhibidores de bromodominio.
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
WO2013057013A3 (en) Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
MX360700B (es) Formulacion concentrada liquida que contiene un insecticida de piripiropeno ii.
MX360698B (es) Formulación concentrada líquida que contiene un insecticida de piripiropeno i.
MX2021009377A (es) Formulaciones de espuma y aparatos para su suministro.
MX362770B (es) Formulación concentrada líquida que contiene un insecticida de piripiropeno iii.
WO2014121764A3 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
MX364610B (es) Derivados de 1- [m-carboxamido (hetero) aril-metil]-heterociclil-c arboxamida.
NZ702342A (en) Pharmaceutical formulation
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
WO2012173458A3 (ko) 식물 세포 내에 안정화된 활성 물질 및 그 제조방법
MX2020003134A (es) Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas.
WO2015038736A3 (en) Formulations for cgrp receptor antagonists
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
EA032913B1 (ru) Препараты производных пиримидиндиона
MX359955B (es) Formulación de aroma y fragancia (iii).
MY170724A (en) Use of certain trioxygenated benzene derivatives in body fat management
WO2011093831A3 (en) Effervescent formulations comprising cefprozil as active agent
WO2012007758A3 (en) Pharmaceutical formulations
MX2015004310A (es) Formulacion de aroma y fragancia (v).
MX360017B (es) Formulación de aroma y fragancia (iv).